BACKGROUND:Amino-terminal B-type natriuretic peptide (NT-proBNP) may detect early cardiac dysfunction in adults with tetralogy of Fallot (ToF) late after corrective surgery. We aimed to determine the value of NT-proBNP in adults with ToF and establish its relationship with echocardiography and exercise capacity. METHODS AND RESULTS:NT-proBNP measurement, electrocardiography and detailed 2D-echocardiography were performed on the same day in 177 consecutive adults with ToF (mean age 34.6± 11.8 years, 58% male, 89% NYHA I, 29.3 ± 8.5 years after surgical correction). Thirty-eight percent of the patients also underwent a cardiopulmonary-exercise test. Median NT-proBNP was 16 [IQR 6.7-33.6] pmol/L, and was elevated in 55%. NT-proBNP correlated with right ventricular (RV) dilatation (r = 0.271, p < 0.001) and RV systolic dysfunction (r = -0.195, p = 0.022), but more strongly with LV systolic dysfunction (r=-0.367, p<0.001), which was present in 69 patients (39%). Moderate or severe pulmonary regurgitation was not associated with higher NT-proBNP. Tricuspid and pulmonary regurgitation peak velocities correlated with NT-proBNP (r = 0.305, p < 0.001 and r = 0.186, p = 0.045, respectively). LV twist was measured with speckle-tracking echocardiography in 71 patients. An abnormal LV twist (20 patients, 28%) was associated with elevated NT-proBNP (p = 0.030). No relationship between NT-proBNP and exercise capacity was found. CONCLUSIONS:NT-proBNP levels are elevated in more than 50% of adults with corrected ToF, while they are in stable clinical condition. Higher NT-proBNP is most strongly associated with elevated pulmonary pressures, and with LV dysfunction rather than RV dysfunction. NT-proBNP has the potential to become routine examination in patients with ToF to monitor ventricular function and may be used for timely detection of clinical deterioration.
RCT Entities:
BACKGROUND: Amino-terminal B-type natriuretic peptide (NT-proBNP) may detect early cardiac dysfunction in adults with tetralogy of Fallot (ToF) late after corrective surgery. We aimed to determine the value of NT-proBNP in adults with ToF and establish its relationship with echocardiography and exercise capacity. METHODS AND RESULTS: NT-proBNP measurement, electrocardiography and detailed 2D-echocardiography were performed on the same day in 177 consecutive adults with ToF (mean age 34.6 ± 11.8 years, 58% male, 89% NYHA I, 29.3 ± 8.5 years after surgical correction). Thirty-eight percent of the patients also underwent a cardiopulmonary-exercise test. Median NT-proBNP was 16 [IQR 6.7-33.6] pmol/L, and was elevated in 55%. NT-proBNP correlated with right ventricular (RV) dilatation (r = 0.271, p < 0.001) and RV systolic dysfunction (r = -0.195, p = 0.022), but more strongly with LV systolic dysfunction (r=-0.367, p<0.001), which was present in 69 patients (39%). Moderate or severe pulmonary regurgitation was not associated with higher NT-proBNP. Tricuspid and pulmonary regurgitation peak velocities correlated with NT-proBNP (r = 0.305, p < 0.001 and r = 0.186, p = 0.045, respectively). LV twist was measured with speckle-tracking echocardiography in 71 patients. An abnormal LV twist (20 patients, 28%) was associated with elevated NT-proBNP (p = 0.030). No relationship between NT-proBNP and exercise capacity was found. CONCLUSIONS: NT-proBNP levels are elevated in more than 50% of adults with corrected ToF, while they are in stable clinical condition. Higher NT-proBNP is most strongly associated with elevated pulmonary pressures, and with LV dysfunction rather than RV dysfunction. NT-proBNP has the potential to become routine examination in patients with ToF to monitor ventricular function and may be used for timely detection of clinical deterioration.
Authors: Eva van den Bosch; Judith A A E Cuypers; Saskia E Luijnenburg; Nienke Duppen; Eric Boersma; Ricardo P J Budde; Gabriel P Krestin; Nico A Blom; Hans M P J Breur; Miranda M Snoeren; Jolien W Roos-Hesselink; Livia Kapusta; Willem A Helbing Journal: Eur Heart J Cardiovasc Imaging Date: 2020-09-01 Impact factor: 6.875
Authors: Jamie K Harrington; Sunil Ghelani; Nikhil Thatte; Anne Marie Valente; Tal Geva; Julia A Graf; Minmin Lu; Lynn A Sleeper; Andrew J Powell Journal: J Cardiovasc Magn Reson Date: 2021-05-24 Impact factor: 5.364
Authors: R C Schoonbeek; P G Pieper; Y J van Slooten; H G Freling; G T Sieswerda; A P J van Dijk; M R M Jongbloed; M C Post; B J Bouma; R M F Berger; T Ebels; J P van Melle Journal: Neth Heart J Date: 2016-11 Impact factor: 2.380
Authors: Gernot Grangl; Evelyn Zöhrer; Martin Köstenberger; Alexandra Jud; Günter Fauler; Hubert Scharnagl; Tatjana Stojakovic; Robert Marterer; Andreas Gamillscheg; Jörg Jahnel Journal: PLoS One Date: 2015-12-11 Impact factor: 3.240